4//SEC Filing
Francomano Robert 4
Accession 0001104659-20-057631
CIK 0001264587other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 9:31 PM ET
Size
5.9 KB
Accession
0001104659-20-057631
Insider Transaction Report
Form 4
Francomano Robert
Chief Commercial Officer
Transactions
- Sale
Common Stock
2020-05-04$11.51/sh−272$3,131→ 197,658 total
Footnotes (3)
- [F1]In connection with the vesting of 1,878 shares on May 2, 2020 a total of 272 shares were sold by the Company on May 4, 2020 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for the shares sold on May 4, 2020 was $11.81 to $12.02. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F3]Of the shares listed, 144,425 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001797467
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 9:31 PM ET
- Size
- 5.9 KB